Locoregional Recurrence of Breast Conserving Surgery after Preoperative Chemotherapy in Korean Women with Locally Advanced Breast Cancer.
10.4048/jbc.2011.14.4.289
- Author:
Seeyoun LEE
1
;
Seok Won KIM
;
Seok Ki KIM
;
Keun Seok LEE
;
Eun A KIM
;
Youngmee KWON
;
Kyung Hwan SHIN
;
Han Sung KANG
;
Jungsil RO
;
Eun Sook LEE
Author Information
1. Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea. eslee@nee.re.kr
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Breast neoplasms;
Breast-conserving surgery;
Local recurrence neoplasm;
Neoadjuvant therapy
- MeSH:
Breast;
Breast Neoplasms;
Disease-Free Survival;
Female;
Humans;
Mastectomy;
Mastectomy, Segmental;
Multivariate Analysis;
Neoadjuvant Therapy;
Random Allocation;
Recurrence
- From:Journal of Breast Cancer
2011;14(4):289-295
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Preoperative chemotherapy has been used to increase the rate of breast conserving surgery (BCS) in Caucasian women. However, whether it would also increase the rate of BCS in Korean women has not been verified. The aim of this study was to determine the effectiveness of preoperative chemotherapy to make BCS possible in Korean women who have locally advanced cancer without any increase of locoregional recurrence according to operation methods (BCS vs. mastectomy). METHODS: From August 2002 to April 2005, 205 patients with stage II or III breast cancer were enrolled in a phase III randomized trial of preoperative chemotherapy. Surgeons decided on the type of surgery (mastectomy or BCS) at initial diagnosis. By randomization, patients received four cycles of either docetaxel/capecitabine or doxorubicin/cyclophosphamide followed by surgery and crossover to the other treatment as postoperative chemotherapy. RESULTS: The mean tumor size was 3.29 cm and the mean breast volume was 489 cc at diagnosis. After preoperative chemotherapy, clinical response was shown in 76.0% of the patients. Of the 71 patients planned for a mastectomy at initial diagnosis, 27 patients underwent BCS (38.0%). Clinical T stage after preoperative chemotherapy, pathologic T size and lymphatic invasion were correlated with conversion to BCS. In multivariate analysis, only lymphatic invasion showed statistical significance. Locoregional disease-free survival did not statistically differ between the two operation methods for the patients who were planned for a mastectomy at the initial exam. CONCLUSION: This study showed that preoperative chemotherapy also increased the rate of BCS, while avoiding any increase of locoregional recurrence in Korean women with locally advanced breast cancer.
